NanovelosS.A.Status: Entity active
Research and experimental development in natural sciences and engineering
KRS: 0000581695 NIP: 9522123769 REGON: 14659524700000
Overview
Registry date
2015-10-30
Share capital
$271,291.41
Activity description
Nanovelos is a biotechnology company specializing in the use of nanotechnology for oncological therapies. It develops polysaccharide-based drug carriers aimed at precise drug delivery for cancer treatment, specifically working on an effective drug using epirubicin (PolEpi) for ovarian cancer therapy. The company's technology aims to enhance treatment efficacy while minimizing adverse effects on patients.
Registered address
Ul. Rakowiecka 36, 02-532 Warszawa, Poland
Website
nanovelos.comWebsite active
Industry
| Name | Code |
|---|---|
Research and experimental development in natural sciences and engineeringPrimary | 72.10.Z |
Manufacture of pharmaceutical preparations | 21.20.Z |
Other engineering activities and related technical consultancy | 71.12.B |
Other technical testing and analysis | 71.20.C |
Business and other management consultancy activities | 70.20.Z |
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| VET Cell Techsp. z o.o. | $39,126.53 | vetcelltech.com | |
| Pro-Eko-Energiasp. z o.o. | $20,327.74 | pro-eko-energia.pl | |
| Inkubuj.Plsp. z o.o. | $15,919.57 | cleverinvestment.pl | |
| Innoeco Polskasp. z o.o. | $13,797.29 | innoeco.pl | |
| NanotheaS.A. | $12,468.30 | nanothea.com | |
| Bio2materialssp. z o.o. | $5,559.26 | bio2materials.com | |
| Biotargetsp. z o.o. | $963.92 | biotarget.eu | |
| Nextgen Materialssp. z o.o. | $367.08 | fruitonauts.com/ | |
| Adapt-Esp. z o.o. | — | adapt-e.com | |
| Alpha Omega Engineeringsp. z o.o. | — | wolska 58/1 |
Last updated: 2026-03-21